source
- Vertex’s latest autoimmune TCE play involves $28M upfront to AbCelleraAbCellera’s T-cell engager platform has reeled in a second client this summer, with Vertex paying $28 million upfront for a collaboration that will include autoimmune conditions.Fierce Biotech · 10h ago↗ source
- Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warnA Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S. could lose out on foreign scientists